MannKind Corporation
Furoscix ReadyFlow Autoinjector
Resolved
26days ago
FDA decision · Jul 26, 2026
What's at stake
The FDA's approval decision on Furoscix ReadyFlow Autoinjector for its lead indication is due Jul 26, 2026. A green light opens the market; a complete response letter (CRL) usually sinks the stock.
Primary source
· SEC 8-K
verified 2mo ago
“Furoscix ReadyFlow Autoinjector PDUFA date July 26, 2026”